OSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1 and OSE-230 Preclinical Programs in Immuno-Oncology and Immuno-Inflammation At International Conferences

OSE Immunotherapeutics SA presents scientific updates in oral and poster presentations selected for international conferences: at the Antibody Engineering & Therapeutics Europe 2023 Conference in Amsterdam, Netherlands, at the FOCIS 2023 Annual Meeting, the 4th Annual Cytokine-Based Drug Development Summit 2023 and at the 3rd Annual Tumor Myeloid-directed Therapies Summit 2023 in Boston, US.

Scroll to Top